Aminoleban EN Adverse Reactions

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

The information highlighted (if any) are the most recent updates for this brand.

Full Prescribing Info

Adverse Reactions

Adverse reactions to AMINOLEBAN EN powder, including abnormalities in laboratory data, were reported in 185 out of 2,628 patients treated (7.04%). (Figures are total cases reported at the time of approval and at the completion of reexamination.)
The following summary of data includes adverse reactions voluntarily reported after marketing.
Clinically significant adverse reactions: Hypoglycemia (<0.1%): Hypoglycemia (cold sweat, feeling abnormal, shivering, palpitations, etc.) may occur. If such signs or symptoms are observed, appropriate measures should be taken.
Other adverse reactions: See Table 2.

Click on icon to see table/diagram/image

View ADR Reporting Link

Aminoleban EN Adverse Reactions

Manufacturer:

Otsuka

Distributor:

Zuellig

Agencia Lei Va Hong